Photo showing a doctor with gloves on inserting a swab into a tube for a pathology review of cancer cells

Medicine’s Sanford Markowitz discusses cancer detection company developed by CWRU, University Hospitals

Medtech company with ties to CWRU, UH completes $70 million IPO

Crain’s Cleveland Business: Sanford Markowitz, the Ingalls Professor of Cancer Genetics and Medicine at the School of Medicine, discussed the $70 million initial public offering of Lucid Diagnostics, a company that makes esophageal cancer tests, developed by faculty at the School of Medicine and University Hospitals.